What's next for immunotherapy in locally advanced NSCLC?
Publication
, Journal Article
Ready, NE
Published in: Clinical advances in hematology & oncology : H&O
May 2021
Duke Scholars
Published In
Clinical advances in hematology & oncology : H&O
ISSN
1543-0790
Publication Date
May 2021
Volume
19
Issue
5
Start / End Page
302 / 304
Related Subject Headings
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Immunologic Factors
- Humans
- Carcinoma, Non-Small-Cell Lung
Citation
APA
Chicago
ICMJE
MLA
NLM
Ready, N. E. (2021). What's next for immunotherapy in locally advanced NSCLC? Clinical Advances in Hematology & Oncology : H&O, 19(5), 302–304.
Ready, Neal Edward. “What's next for immunotherapy in locally advanced NSCLC?” Clinical Advances in Hematology & Oncology : H&O 19, no. 5 (May 2021): 302–4.
Ready NE. What's next for immunotherapy in locally advanced NSCLC? Clinical advances in hematology & oncology : H&O. 2021 May;19(5):302–4.
Ready, Neal Edward. “What's next for immunotherapy in locally advanced NSCLC?” Clinical Advances in Hematology & Oncology : H&O, vol. 19, no. 5, May 2021, pp. 302–04.
Ready NE. What's next for immunotherapy in locally advanced NSCLC? Clinical advances in hematology & oncology : H&O. 2021 May;19(5):302–304.
Published In
Clinical advances in hematology & oncology : H&O
ISSN
1543-0790
Publication Date
May 2021
Volume
19
Issue
5
Start / End Page
302 / 304
Related Subject Headings
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Immunologic Factors
- Humans
- Carcinoma, Non-Small-Cell Lung